Prognostic implication of TERT promoter mutation and circulating tumor cells in muscle-invasive bladder cancer.
Raquel CarrascoMercedes Ingelmo-TorresAscensión GómezFiorella L RoldánNatalia SeguraMaría José RibalAntonio AlcarazLaura IzquierdoLourdes MengualPublished in: World journal of urology (2022)
The TERT c.-124C > T mutation could be considered a biomarker of aggressivity. CTC enumeration is a useful tool for identifying MIBC patients at high risk of progression and CSS after RC and for detecting tumor progression earlier than imaging techniques.